Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands.
about
Biological significance of agmatine, an endogenous ligand at imidazoline binding sitesThe imidazoline receptors and ligands in pain modulationChronic morphine induces up-regulation of the pro-apoptotic Fas receptor and down-regulation of the anti-apoptotic Bcl-2 oncoprotein in rat brainEffects of yohimbine on the antinociceptive and place conditioning effects of opioid agonists in rodentsImidazoline receptors and human brain disorders.Antinociceptive effects of sinomenine in a rat model of neuropathic pain.Analgesic efficacy of CR4056, a novel imidazoline-2 receptor ligand, in rat models of inflammatory and neuropathic painProtection by imidazol(ine) drugs and agmatine of glutamate-induced neurotoxicity in cultured cerebellar granule cells through blockade of NMDA receptor.Anti-hyperalgesic effects of imidazoline I2 receptor ligands in a rat model of inflammatory pain: interactions with oxycodone.Effects of the imidazoline I2 receptor agonist 2-BFI on the development of tolerance to and behavioural/physical dependence on morphine in ratsReview: The neuropathology of drug abuse.Opioid adjuvant strategy: improving opioid effectiveness.Imidazoline I2 receptors: An update.Induction of reactive astrocytosis and prevention of motoneuron cell death by the I(2)-imidazoline receptor ligand LSL 60101.Neuronal apoptosis in morphine addiction and its molecular mechanism.Attenuation of acute and chronic effects of morphine by the imidazoline receptor ligand 2-(2-benzofuranyl)-2-imidazoline in rat locus coeruleus neurons.Activation of I(2)-imidazoline receptors enhances supraspinal morphine analgesia in mice: a model to detect agonist and antagonist activities at these receptors.Widespread but regionally specific effects of experimenter- versus self-administered morphine on dendritic spines in the nucleus accumbens, hippocampus, and neocortex of adult rats.Regulation of nonphosphorylated and phosphorylated forms of neurofilament proteins in the prefrontal cortex of human opioid addicts.Chronic treatment with selective I2-imidazoline receptor ligands decreases the content of pro-apoptotic markers in rat brain.2-(2-benzofuranyl)-2-imidazoline (2-BFI) improved the impairments in AD rat models by inhibiting oxidative stress, inflammation and apoptosis.Pharmacologic and molecular discrimination of I2-imidazoline receptor subtypes.Evaluation and initial in vitro and ex vivo characterization of the potential positron emission tomography ligand, BU99008 (2-(4,5-dihydro-1H-imidazol-2-yl)-1- methyl-1H-indole), for the imidazoline₂ binding site.Chronic oxycodone induces axonal degeneration in rat brain.
P2860
Q24673628-FC3925BD-F7AE-414A-A8F0-10099A42DEE6Q26776329-50CD6832-C785-4A4C-835C-F37709AE7F27Q28363748-8369F708-2E3D-4673-AEC3-2DE663C6C7E8Q28363862-0EA96C13-25CB-46D0-ACDD-62FB33BDAABBQ33693078-72C446F1-C7E9-4B62-8FDA-5CC255959A6FQ34590072-5FCA76A7-7061-4580-A74D-8E13AF4D948DQ34999759-E577C77C-A4BD-498B-BBFA-2F0DEC684B49Q35566498-6FDA5993-D695-44F2-8793-F187C8303ECCQ35958210-E697BB00-1CA7-4AD5-A894-7B2EB389272DQ37084868-242D03B3-260B-45C3-A131-E2F7C3EA5BFDQ37800120-7C274B8E-F84D-4322-B99E-7BB2A76C2BD9Q38742586-AC59C274-3CC2-4D5D-B6FE-8174E5A184F0Q39189902-8682EE17-E1F8-4D76-A9DE-3424755C8805Q41906787-147C37DC-1FDD-4095-9238-6E1B1A5C11ACQ42136676-A9B726AB-387F-42EB-9F36-CC5A097DF6CEQ43263537-A7A7F4B8-37F6-4D42-BD4D-ADFD36BAA687Q43264170-6CD5DEE9-C114-4B53-B74E-992282A0B1DFQ44175285-FAD99C92-FF6E-40D4-A6BF-FA52754B65A0Q44332350-D4797754-4DBF-4900-89A4-4EF7B81A3810Q45851009-21BA9852-52DA-4004-9939-C45CE298CEF5Q46309260-A29EE510-7392-4FC3-AF50-09301B89FC4CQ48155212-0F32303F-40E0-4FDA-B966-A52B5974C817Q48683741-BDD71ACA-C4DB-491A-A262-31A948DE9FF4Q51735904-B687A518-EA13-407C-9F91-07AFBAE92295
P2860
Attenuation of tolerance to opioid-induced antinociception and protection against morphine-induced decrease of neurofilament proteins by idazoxan and other I2-imidazoline ligands.
description
1998 nî lūn-bûn
@nan
1998 թուականի Սեպտեմբերին հրատարակուած գիտական յօդուած
@hyw
1998 թվականի սեպտեմբերին հրատարակված գիտական հոդված
@hy
1998年の論文
@ja
1998年論文
@yue
1998年論文
@zh-hant
1998年論文
@zh-hk
1998年論文
@zh-mo
1998年論文
@zh-tw
1998年论文
@wuu
name
Attenuation of tolerance to op ...... other I2-imidazoline ligands.
@ast
Attenuation of tolerance to op ...... other I2-imidazoline ligands.
@en
type
label
Attenuation of tolerance to op ...... other I2-imidazoline ligands.
@ast
Attenuation of tolerance to op ...... other I2-imidazoline ligands.
@en
prefLabel
Attenuation of tolerance to op ...... other I2-imidazoline ligands.
@ast
Attenuation of tolerance to op ...... other I2-imidazoline ligands.
@en
P2860
P356
P1476
Attenuation of tolerance to op ...... d other I2-imidazoline ligands
@en
P2093
Boronat MA
García-Sevilla JA
P2860
P304
P356
10.1038/SJ.BJP.0702031
P407
P50
P577
1998-09-01T00:00:00Z